GlassScriptPhysician profile
Michael Anthony Warren
NPI 1013032069
$1,236.04
in general payments reported to CMS, 2019-2025
10 companies · $211 in 2025
The $211 reported for 2025 was more than what 76% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.17 · 2020: $130 · 2021: $109 · 2022: $436 · 2023: $223 · 2024: $80.40 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $303 · Gift: $211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $303.28 |
| Gift | $210.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultradent Products INC | $507.30 | 2022-2025 | Opalescence |
| Align Technology, INC. | $195.76 | 2020-2023 | Itero Element 5d |
| Nobel Biocare USA | $141.05 | 2021-2023 | Nobelactive |
| Hu-Friedy Mfg. Co., LLC | $122.12 | 2022 | |
| Biolase, INC. | $84.88 | 2023 | Waterlase Iplus |
| Dentsply Sirona INC | $62.38 | 2019-2024 | Waveone Gold Conform Fit |
| Straumann USA LLC | $46.37 | 2024 | |
| 3m Company | $39.88 | 2020 | |
| Biohorizons Implant Systems INC. | $18.82 | 2024 | Biohorizons |
| Orapharma, A Division of Bausch Health US, LLC | $17.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Warren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.